Lipid Accumulation in Blastocystis Increases Cell Damage in Co-Cultured Cells

Chen-Chieh Liao1, Chun-Hsien Chen1,2, Jyh-Wei Shin1,3

  • 1Department of Parasitology, Institute of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.

Microorganisms
|June 28, 2023
PubMed

Insights

Lipids significantly worsen Blastocystis hominis infections by increasing inflammation and parasite virulence. Lowering lipids with pravastatin reduced these harmful effects, suggesting new treatment strategies for Blastocystis infections.

Area of Science:

  • Microbiology
  • Parasitology
  • Molecular Biology

Background:

  • Blastocystis hominis is an underappreciated intestinal protozoan.
  • Lipid accumulation in B. hominis is known, but its role in pathogenesis is unclear.

Purpose of the Study:

  • To investigate the role of lipids in Blastocystis hominis pathogenesis.
  • To explore potential therapeutic interventions targeting lipid metabolism.

Main Methods:

  • Culturing Blastocystis ST7-B with and without lipid supplements.
  • Assessing parasite-induced inflammation and Caco-2 cell disruption.
  • Measuring cysteine protease activity.
  • Treating cultures with the lipid-lowering drug pravastatin.
  • Analyzing fatty acid composition.

Main Results:

  • Lipid-rich Blastocystis ST7-B exhibited increased inflammation and Caco-2 cell disruption.
  • Lipid-rich parasites showed upregulated cysteine protease activity.
  • Pravastatin treatment reduced lipid levels, inflammation, and cell damage.
  • Key fatty acids like arachidonic, oleic, and palmitic acids were elevated in lipid-rich Blastocystis.

Conclusions:

  • Lipids play a critical role in Blastocystis hominis pathogenesis.
  • Targeting lipid metabolism, for example with pravastatin, offers a potential therapeutic strategy.
  • Understanding lipid pathways provides insights into Blastocystis infection mechanisms.